There is access to more electronic health record (EHR) data than ever before, but we’ve only just scratched the surface of its potential for modernizing clinical research enrollment.
EHR data comes from many different sources and is stored in different locations and formats with varying degrees of quality. If a researcher wants to use EHR data to find patients for their study, they need to go across several data partners to collect the data, sift through it, and then find a way to query it for eligible patients.
How can these disparate data sources be unified to efficiently find and enroll patients in studies?
Join the Elligo Elite Learning Series round table “Solve Clinical Trial Enrollment Struggles With Better Utilization of Healthcare Data” for expert insights and engaging discussion surrounding the future of EHR data and clinical trial enrollment. This webinar will feature industry leaders from the US Food and Drug Administration (FDA), Freenome, Cerner Enviza, Deep Lens, and Elligo Health Research®. The discussion will also explore potential pitfalls of healthcare data as well as solutions and strategies for overcoming them.
Michael Ibara, Pharm.D., Chief Data Officer, Elligo Health Research®
Michael Ibara has more than 20 years of experience in clinical research and development. Throughout his career, Ibara has sought to improve healthcare by bringing together healthcare data and digital technologies. His interests include regulatory and policy implications for digital healthcare, exploring the factors needed to allow interoperability of healthcare data for all stakeholders involved, and implications for the use of big data, machine learning and natural language processing to improve our ability to perform regulated clinical research.
Before joining Elligo, Ibara was the head of digital healthcare for the Clinical Data Interchange Standards Consortium (CDISC). There, he led the FDA eSource project and Healthcare Link efforts with registries, clinical trials and mobile health to enable use of real-world data from healthcare for regulated research and decision making. Prior to CDISC, Ibara was head of business development coordination and innovation and also head of pharmacovigilance innovation at Pfizer, where he worked for 15 years in various positions, leading implementations of global systems and large-scale technologies.Message Presenter
Dr. TJ Bowen, Chief Scientific Officer & Co-Founder, Deep Lens
Dr. Bowen brings a diverse set of skills to the team. Prior to joining Deep Lens, Dr. Bowen’s career has spanned from cancer research to software development and strategy and management consulting. His research focused on pathological identification of tumor differentiation in breast cancers derived from p53, BRCA1/2, ATM and other mutations.
Dr. Bowen has also held operating roles as the general manager of the world’s premium biology and pharmaceutical patent search software at CAS.
More recently, Dr. Bowen was a founding leader of the software innovation team at Fuse by Cardinal Health where his teams developed innovative products for healthcare providers, pharmaceutical companies and patients.
Dr. Bowen was a Regents Scholar at the University of California, San Diego where he received his doctorate in Biomedical Sciences and graduated with Honors from Pepperdine University with a BS in Biology.
Mitra Rocca, Dipl.-Inform. Med., FAMIA, Senior Medical Informatician, FDA
Mitra Rocca joined Food and Drug Administration (FDA) in 2009 as the Senior Medical Informatician responsible for developing the health information architecture of the Sentinel System. She serves as the lead for the FDA CDER health information technology (health IT) board focusing on the use of health IT to enhance regulatory decision making. She serves as the FDA CDER lead to Health Level Seven (HL7), responsible for the review of HL7 draft standards.
Prior to joining FDA, Mitra served as the Associate Director, Healthcare Informatics at Novartis Pharmaceuticals Corporation focusing on the reuse of the Electronic Health Record (EHR) in clinical research. Mitra has served as the co-chair of the Health Level Seven (HL7) Clinical Interoperability Council (CIC) from 2012-2018. She holds her advanced degree in Medical Informatics from the University of Heidelberg in Germany.Message Presenter
Riley Ennis, Chief Product Officer, Freenome
With the knowledge and skills he gained as a biotechnology entrepreneur, Riley is helping to make Freenome’s vision of a cancer-free world a reality. As the company’s co-founder and Chief Product Officer, Riley heads the clinical and commercial development of Freenome’s non-invasive tests for early cancer detection and treatment selection.
A Thiel Fellow, Riley developed a cancer vaccine and founded his first biotech company, Immudicon, while still in high school. While earning his degree in molecular biology at Dartmouth, Riley co-authored several publications and worked as a visiting scientist with Novartis.
In addition to his work as a scientist, Riley worked as an analyst at Morgan Stanley and an associate at Bridgewater, where he observed the positive impact of a strong organizational culture firsthand. Riley’s previous biotech experience includes work at Foundation Medicine, Syros Pharmaceuticals, Adimab, and Emergent Biosolutions.Message Presenter
Jeremy Brody, Head of Global Strategy, Cerner Enviza
Jeremy Brody is the head of global strategy and a member of the executive committee of Cerner Enviza. Jeremy’s primary responsibility is to lead corporate development activities, furthering the Enviza’s strategy and fueling the growth of the business. Areas of particular focus include real world evidence, advanced big data analytics, clinical research, patient-centric applications and digital health.
Before joining Cerner Enviza, Jeremy was the co-founder and CEO of Jstreetdata.com, the first online physician market research panel in the US. This venture-backed startup was acquired by Interpublic Group (NYSE:IPG) in August 2002 and, through subsequent acquisitions, became part of what today is called Cerner Enviza.
Prior to his experience at Covance, Jeremy was a corporate development analyst for Access Health, one of the first consumer-focused health information companies. As a product manager for Blue Cross and Blue Shield of Massachusetts, Jeremy managed an innovative insurance product targeted at college and graduate students in Massachusetts.
Jeremy received a Master of Science in health policy and management from the Harvard University School of Public Health and a Bachelor of Science in psychology from New York University.
Jeremy is based in Israel and keeps his entrepreneurial spirit alive by interacting with start up companies located in the Start-Up Nation’s famous Silicon Wadi. When not at work, Jeremy enjoys spending his time with his wife, 6 boys, and granddaughter who always keep things exciting. He also produces live music concerts at a local café.
Who Should Attend?
The webinar will be of interest to members of the following industries:
- Pharma, Biotech, Medical Device
- Clinical operations
- Medical affairs
What You Will Learn
In this webinar, the featured speakers will discuss:
- How EHR data can improve clinical trial enrollment
- What difficulties sponsors might face when using EHR data to enroll studies
- How to overcome these difficulties to keep a trial on time and on budget
- The exciting future of healthcare data and clinical research
Elligo Health Research®
Elligo Health Research accelerates clinical trials through healthcare with access to known patients and their HIPAA-compliant healthcare data, our IntElligo® Research Stack technology, and our eSolutions Research Accelerator PatientSelect approach. As the largest Known Patient Access Network, our ClinEdge Research Practice Management enables healthcare practices and research sites to participate in clinical trials as Research Ready. By adaptive engagement of known patients and physicians, these services dramatically accelerate the development of new pharmaceutical, biotechnology, and medical device and diagnostic products.